PDCO
38
2
NEE
50
3
BF.B
31
2
KHC
22
-3
SHW
65
9
NAVI
43
16
CAH
44
-6
XRX
30
2
STZ
50
7
ABBV
57
-2
TXN
46
-2
XRAY
34
11
LEG
28
6
PNR
65
3
LEN
52
4
FOXA
59
7
EXR
48
2
HIG
52
2
LUV
39
-5
MAT
62
2
PDCO
38
2
NEE
50
3
BF.B
31
2
KHC
22
-3
SHW
65
9
NAVI
43
16
CAH
44
-6
XRX
30
2
STZ
50
7
ABBV
57
-2
TXN
46
-2
XRAY
34
11
LEG
28
6
PNR
65
3
LEN
52
4
FOXA
59
7
EXR
48
2
HIG
52
2
LUV
39
-5
MAT
62
2
Financhill
Back

Structure Therapeutics Vs. Novo Nordisk AS Industry Stock Comparison

Sell
40

GPCR
Structure Therapeutics

Last Price:
39.29
Seasonality Move:
-35.87%
Sell
35

NVO
Novo Nordisk AS

Last Price:
110.04
Seasonality Move:
7.98%
Sell
40
Structure Therapeutics (GPCR) is a Sell

Is Structure Therapeutics a Buy, Sell or Hold?

  • The current Structure Therapeutics [GPCR] share price is $39.74. The Score for GPCR is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • GPCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $109.72. The Score for NVO is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GPCR Stock Price Chart

What is Structure Therapeutics's stock price today?

  • The Structure Therapeutics share price today is $39.74
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing selling pressure, which indicates risk of future bearish movement.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $109.72
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 51.34 Buy
Chaikin Money Flow: -625102 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.61 - 41.77) Buy
Bollinger Bands (100): (36.09 - 43.17) Buy

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.42 Sell
Relative Strength Index (14 RSI): 26.63 Sell
Chaikin Money Flow: -3321918 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (113.06 - 118.54) Sell
Bollinger Bands (100): (120.25 - 140.23) Sell

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.92 Buy
20-day SMA: 38.87 Buy
50-day SMA: 39.6 Buy
200-day SMA: 40.28 Sell
8-day EMA: 39.45 Buy
20-day EMA: 39.31 Buy
50-day EMA: 39.42 Buy
200-day EMA: 39.73 Buy

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.31 Sell
20-day SMA: 115.56 Sell
50-day SMA: 124.03 Sell
200-day SMA: 128.23 Sell
8-day EMA: 112.48 Sell
20-day EMA: 115.49 Sell
50-day EMA: 121.45 Sell
200-day EMA: 122.82 Sell

Structure Therapeutics Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.07 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.87 per share.

Structure Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):